RS BioTherapeutics Creates Therapeutic Expert Council to Provide Guidance on Development of First-in-Class Agent Focused on Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
21 févr. 2024 09h52 HE
|
RS BioTherapeutics
RS BioTherapeutics is pleased to announce the formation of its Therapeutic Expert Council (TEC).
Labcorp Elevates Employee Health Benefits with WeightWatchers for Business Full-Spectrum Weight Health Platform
07 févr. 2024 09h05 HE
|
WW International Inc.
NEW YORK and BURLINGTON, N.C., Feb. 07, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) today announced that Labcorp (NYSE: LH), a global leader of...
Central Fill Pharmacy Automation Market Size Worth USD 1,520.43 Million in 2032 | Emergen Research
01 févr. 2024 11h36 HE
|
Emergen Research
Vancouver, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The global central fill pharmacy automation market size was USD 523 Million in 2022 and is expected to register a revenue CAGR of 11.20% during the...
WeightWatchers Unveils “Beyond Hunger: Understanding Food Noise” Report Offering Insights Into the Experience of Ongoing, Intrusive Thoughts About Food
16 janv. 2024 09h16 HE
|
WW International Inc.
Findings of WeightWatcher's “Beyond Hunger: Understanding Food Noise” report, focus on the experience of people living with "food noise".
WeightWatchers Launches New Behavior Change Program Designed to Support the Unique Needs of Individuals on GLP-1 Medications
14 déc. 2023 09h00 HE
|
WW International Inc.
NEW YORK, Dec. 14, 2023 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) announced today the launch of WeightWatchers GLP-1 Program to provide tailored...
RS BioTherapeutics and National Institutes of Health Execute Research Collaboration Agreement to Evaluate Prevention and Treatment of Idiopathic Pulmonary Fibrosis
29 août 2023 11h30 HE
|
RS BioTherapeutics
CUMBERLAND, Md., Aug. 29, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, a life sciences company developing life-changing medicines for the millions of people suffering from diseases characterized by...
Amyotrophic Lateral Sclerosis Treatment Market to Reach US$ 594.1 Million in 2031, Expanding at a CAGR of 5.5%: TMR Report
26 juin 2023 13h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 26, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – In 2022, the global industry was estimated to be worth $594.1 million. It is expected to...
RS BioTherapeutics Appoints Michelle L. Shuffett, MD as SVP of Medical and Scientific Affairs
05 juin 2023 07h00 HE
|
RS BioTherapeutics
CUMBERLAND, Md., June 05, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to harness the therapeutic power of cannabinoids in the research, development, and commercialization of life...
Panic Disorder Market Towards US$ 12,621.61 Mn By 2030, A Comprehensive Analysis By Reports Insights
29 mai 2023 05h00 HE
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, May 29, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Reports Insights, the panic disorder market is poised for strong expansion and is expected to reach USD 12,621.61 Million...
Facial Wrinkle Treatment Market Size To Hit US$ 472.2 billion By 2033, Owing To Increasing Investments in Healthcare Sector Globally | Persistence Market Research
30 mars 2023 09h20 HE
|
Persistence Market Research
New York, March 30, 2023 (GLOBE NEWSWIRE) -- As per Persistence Market Research, the global facial wrinkle treatment market was valued at US$ 77.2 billion in 2022 and is projected to surge ahead at...